Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 3
Review
Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
13,661 | Dovepress* | 11,211+ | 4,576 | 15,787 | |
PubMed Central* | 2,450 | 133 | 2,583 | ||
Totals | 13,661 | 4,709 | 18,370 | ||
*Since 4 August 2011 +Since July 2016 |
View citations on PubMed Central and Google Scholar